Vision Financial Markets’s Biogen BIIB Stock Holding History

Vision Financial Markets’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.2K	Hold	200	–	–	0.04%	146
2026 Q1	$36.7K	Hold	200	–	–	0.04%	139
2025 Q4	$35.2K	Hold	200	–	–	0.04%	139
2025 Q3	$28K	Hold	200	–	–	0.02%	172
2025 Q2	$25.1K	Hold	200	–	–	0.02%	169
2025 Q1	$27.4K	Buy	+200	New	+$28.6K	0.03%	145

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Vision Financial Markets's BIIB Position: Q2 2026 in Review

Vision Financial Markets held its Biogen (BIIB) position steady in Q2 2026 at 200 shares worth $43.2K. The position accounts for 0.04% of the portfolio, ranked #146.

Vision Financial Markets first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. 350 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Vision Financial Markets held 200 shares of Biogen worth $43.2K as of Q2 2026.
Vision Financial Markets left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.04% of Vision Financial Markets's portfolio in Q2 2026, its #146 holding.
Vision Financial Markets first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
350 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.